Acorda (acor) was on Jim Cramers Mad Money tonight about Parkinson's.
CVT-301 inhaler entering phase 3.
Cramer stated isn't anything in the lungs per FDA worrisome?
Sounds like AMBS is better.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
